Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

Maintaining Clinical Trial Patient Engagement in COVID with Be the Partner

  • Broadcast in Science
Pharma Talk Radio

Pharma Talk Radio

×  

Follow This Show

If you liked this show, you should follow Pharma Talk Radio.
h:548881
s:11722471
archived

The COVID-19 pandemic has meant that, more and more, clinical trials are being disrupted or interrupted completely. Without the continuous momentum and contact, trials will lose patients as gaps in studies lengthen. 

To combat that, Be the Partner designed “Bridge,” a new solution on their Patient Portal specifically for continuing secure, ongoing connectivity with trial patients during any temporary pauses in trials as a result of COVID-19. The end goal of “Bridge” is to maintain patient engagement throughout the trial’s indefinite pause and aid in a successful relaunch at the appropriate time.

For more information go to or contact www.bethepartner.com

Facebook comments

Available when logged-in to Facebook and if Targeting Cookies are enabled